Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Payables (2018 - 2025)

Verastem has reported Payables over the past 8 years, most recently at $12.4 million for Q4 2025.

  • Quarterly results put Payables at $12.4 million for Q4 2025, up 209.19% from a year ago — trailing twelve months through Dec 2025 was $12.4 million (up 209.19% YoY), and the annual figure for FY2025 was $12.4 million, up 209.19%.
  • Payables for Q4 2025 was $12.4 million at Verastem, up from $10.1 million in the prior quarter.
  • Over the last five years, Payables for VSTM hit a ceiling of $12.4 million in Q4 2025 and a floor of $641000.0 in Q3 2021.
  • Median Payables over the past 5 years was $5.2 million (2022), compared with a mean of $5.4 million.
  • Biggest five-year swings in Payables: plummeted 86.31% in 2021 and later surged 736.04% in 2022.
  • Verastem's Payables stood at $2.3 million in 2021, then soared by 124.85% to $5.2 million in 2022, then surged by 38.79% to $7.2 million in 2023, then tumbled by 43.96% to $4.0 million in 2024, then soared by 209.19% to $12.4 million in 2025.
  • The last three reported values for Payables were $12.4 million (Q4 2025), $10.1 million (Q3 2025), and $8.5 million (Q2 2025) per Business Quant data.